(Q36577550)

15 August 2017

1 reference

title

Tumour-induced immune modulation of sentinel lymph nodes (English)

1 reference

15 August 2017

0 references

Alistair J Cochran

1

1 reference

15 August 2017

Rong-Rong Huang

2

1 reference

15 August 2017

Jonathan Lee

3

1 reference

15 August 2017

Eijun Itakura

4

1 reference

15 August 2017

Stanley P L Leong

5

1 reference

15 August 2017

Richard Essner

6

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Nature Reviews Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

9

1 reference

15 August 2017

page(s)

659-670

1 reference

https://scigraph.springernature.com/pub.10.1038/nri1919

15 August 2017

exact match

0 references

cites work

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

1 reference

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells

21 January 2018

1 reference

Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways

21 January 2018

1 reference

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine

21 January 2018

1 reference

Studies concerning the regional lymph node in cancer.I. Initiation of immunity

21 January 2018

1 reference

Technical details of intraoperative lymphatic mapping for early stage melanoma

31 March 2020

1 reference

Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment

31 March 2020

1 reference

The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma

31 March 2020

1 reference

Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.

31 March 2020

1 reference

Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma

31 March 2020

1 reference

Mechanisms and functional significance of tumour-induced dendritic-cell defects

31 March 2020

1 reference

Immune surveillance in the skin: mechanisms and clinical consequences

31 March 2020

1 reference

Dendritic-cell trafficking to lymph nodes through lymphatic vessels

31 March 2020

1 reference

The role of the regional lymph node in breast cancer: a comparison between nodal and systemic reactivity

31 March 2020

1 reference

Variations in lymphokine generation by individual lymph nodes draining human malignant tumors

31 March 2020

1 reference

The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma

31 March 2020

1 reference

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.

31 March 2020

1 reference

Lymphatic drainage of skin to a sentinel lymph node in a feline model.

31 March 2020

1 reference

Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours

31 March 2020

1 reference

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

31 March 2020

1 reference

Outcome of patients with melanoma and histologically negative sentinel lymph nodes

31 March 2020

1 reference

Reliability of sentinel lymph node biopsy for staging melanoma.

31 March 2020

1 reference

Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence

31 March 2020

1 reference

Melanoma recurrence patterns after negative sentinel lymphadenectomy

31 March 2020

1 reference

The place of lymphatic mapping and sentinel node biopsy in oncology

31 March 2020

1 reference

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma

31 March 2020

1 reference

Lymphocyte trafficking across high endothelial venules: dogmas and enigmas

31 March 2020

1 reference

Cytokine expression and dendritic cell density in melanoma sentinel nodes

31 March 2020

1 reference

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

31 March 2020

1 reference

Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma.

31 March 2020

1 reference

Immunobiology of dendritic cells

31 March 2020

1 reference

Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph Nodes

31 March 2020

1 reference

Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas

31 March 2020

1 reference

Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer

31 March 2020

1 reference

Infiltration of antitumor immunocytes into the sentinel node in gastric cancer

31 March 2020

1 reference

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

31 March 2020

1 reference

Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma

31 March 2020

1 reference

High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes

31 March 2020

1 reference

Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer

31 March 2020

1 reference

CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression

31 March 2020

1 reference

Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin

31 March 2020

1 reference

Cytokine profiles of sentinel lymph nodes draining the primary melanoma

31 March 2020

1 reference

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

31 March 2020

1 reference

CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity

31 March 2020

1 reference

Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth

31 March 2020

1 reference

Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity

31 March 2020

1 reference

IDO expression by dendritic cells: tolerance and tryptophan catabolism

31 March 2020

1 reference

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

31 March 2020

1 reference

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

31 March 2020

1 reference

Prevention of allogeneic fetal rejection by tryptophan catabolism

31 March 2020

1 reference

Tryptophan degradation to control T-cell responsiveness

31 March 2020

1 reference

Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites

31 March 2020

1 reference

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

31 March 2020

1 reference

Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes

31 March 2020

1 reference

The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7.

31 March 2020

1 reference

Chemokines: a new classification system and their role in immunity

31 March 2020

1 reference

Natural killer cells and dendritic cells: rendezvous in abused tissues

31 March 2020

1 reference

Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7

31 March 2020

1 reference

Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization

31 March 2020

1 reference

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

31 March 2020

1 reference

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

31 March 2020

1 reference

Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2

31 March 2020

1 reference

Modulation of human macrophage functions by gangliosides

31 March 2020

1 reference

Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiologic characterization

31 March 2020

1 reference

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

31 March 2020

1 reference

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

31 March 2020

1 reference

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

31 March 2020

1 reference

Remodeling of the microenvironment by aggressive melanoma tumor cells

31 March 2020

1 reference

Coevolution of cancer and stromal cellular responses

31 March 2020

1 reference

Phase I study of immunotherapy of metastatic renal cell carcinoma by direct gene transfer into metastatic lesions

31 March 2020

1 reference

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

31 March 2020

1 reference

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

31 March 2020

1 reference

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery

31 March 2020

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

31 March 2020

1 reference

GM-CSF-based cancer vaccines

31 March 2020

1 reference

Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination

31 March 2020

1 reference

Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF

31 March 2020

1 reference

Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor

31 March 2020

1 reference

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

31 March 2020

1 reference

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

31 March 2020

1 reference

Intratumoral immunotherapy with interferon-alpha and interleukin-2 in glioblastoma

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRI1919

1 reference

Dimensions Publication ID

15 August 2017

1025392030

0 references

1 reference